Latest News and Press Releases

FDA approves Discovery Therapeutic Caribe's Phase 3 trial for intralesional rhEGF in severe diabetic foot ulcers.

Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Diabetic foot ulcer is a type of chronic wound that often leads to complications and challenges surgeons to manage such injuries. Diabetic foot ulcer...

Pune, India, Sept. 01, 2022 (GLOBE NEWSWIRE) -- The global diabetic foot ulcer treatment market size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes...

ORLANDO, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly...

Pune, India, May 25, 2021 (GLOBE NEWSWIRE) -- The global “diabetic foot ulcer treatment market” size is projected to showcase remarkable growth on account of the increasing prevalence of diabetes...

Highlights: Venous leg ulcer Phase 2 trial on track:  top-line results mid-NovemberDiabetic foot ulcer pilot clinical study: in development with key US researchersOcular wounds: international patent...